Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | MPL | P40238 | 3/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ATIC | P31939 | 1/20 | 0.42 |
| ▸ | CTRC | Q99895 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8157500 | 0.98 | CYP2D6 (0.59) | CYP2D6ALDH1A1HSD17B10CYP1A2CYP2C19 | |
| Hydrochloric Acid SCHEMBL27596429 | 0.98 | CYP2D6 (0.59) | CYP2D6ALDH1A1HSD17B10CYP1A2CYP2C19 | |
| SCHEMBL8157494 | 0.98 | CYP2D6 (0.59) | CYP2D6ALDH1A1HSD17B10CYP1A2CYP2C19 | |
| SCHEMBL31398447 | 0.85 | CYP2D6 (0.56) | CYP2D6ALDH1A1HSD17B10CYP1A2CYP2C19 | |
| SCHEMBL219389 | 0.85 | CYP2D6 (0.56) | CYP2D6ALDH1A1HSD17B10CYP1A2CYP2C19 | |
| SCHEMBL15851415 | 0.85 | CYP2D6 (0.51) | CYP2D6ALDH1A1HSD17B10CYP1A2CYP2C19 | |
| SCHEMBL10930603 | 0.84 | CYP2D6 (0.48) | CYP2D6ALDH1A1HSD17B10CYP1A2CYP2C19 | |
| SCHEMBL14813073 | 0.84 | CYP2D6 (0.54) | CYP2D6ALDH1A1HSD17B10CYP1A2CYP2C19 | |
| SCHEMBL1247911 | 0.84 | CYP2D6 (0.54) | CYP2D6ALDH1A1HSD17B10CYP1A2CYP2C19 | |
| SCHEMBL564215 | 0.84 | CYP2D6 (0.58) | CYP2D6ALDH1A1HSD17B10CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111138416-A | Preparation method of L-sunitinib malate E-type isomer | 南京华威医药科技集团有限公司 | 2020-05-12 | — | — | CN | claimed |
| EP-1844010-B1 | ISOMERISATION OF PHARMACEUTICAL INTERMEDIATES | LEO PHARMA AS (DK) | 2013-02-13 | — | — | EP | claimed |
| CN-101400649-B | Isomerization of pharmaceutical intermediates | LEO PHARMA AS | 2012-07-04 | — | — | CN | claimed |
| US-8100020-B2 | Compliant and wireless health monitoring sensors for composite structures | Lumimove, Inc., a Missouri Corporation (US) | 2012-01-24 | — | — | US | claimed |
| US-20100095781-A1 | COMPLIANT AND WIRELESS HEALTH MONITORING SENSORS FOR COMPOSITE STRUCTURES | LUMIMOVE, INC., D/B/A CROSSLINK (US) | 2010-04-22 | — | — | US | claimed |
| CN-101400649-A | Isomerization of pharmaceutical intermediates | LEO PHARMA AS (DK) | 2009-04-01 | — | — | CN | claimed |
| EP-1844010-A1 | ISOMERISATION OF PHARMACEUTICAL INTERMEDIATES | LEO PHARMA A/S (DK) | 2007-10-17 | — | — | EP | claimed |
| US-20070215455-A1 | Isomerisation of pharmaceutical intermediates | LEO PHARMA A/S (DK) | 2007-09-20 | — | — | US | claimed |
| WO-2007082533-A1 | ISOMERISATION OF PHARMACEUTICAL INTERMEDIATES | LEO PHARMA A/S (DK) | 2007-07-26 | — | — | WO | claimed |
| US-4548907-A | Fluorescent fluid determination method and apparatus | ALLIED CORPORATION (US) | 1985-10-22 | — | — | US | claimed |
| EP-0137157-A2 | Fluid analysis technology using fluorescence type sensors | Fisher Scientific Company (US) | 1985-04-17 | — | — | EP | claimed |
| US-20240231230-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM | NISSAN CHEMICAL CORPORATION (JP) | 2024-07-11 | — | — | US | disclosed |
| WO-2024116910-A1 | COMPOSITION AND METHOD FOR ENHANCING SILICON NITRIDE POLISHING RATE SELECTIVITY | 株式会社フジミインコーポレーテッド | 2024-06-06 | — | — | WO | disclosed |
| WO-2023189799-A1 | SELF CROSS-LINKABLE POLYMER AND RESIST UNDERLAYER FILM-FORMING COMPOSITION | 日産化学株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023189803-A1 | RESIST UNDERLAYER FILM FORMING COMPOSITION | 日産化学株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-1990010297-A1 | THERMALLY STABLE FORMS OF ELECTRICALLY CONDUCTIVE POLYANILINE | ALLIED-SIGNAL INC. (US) | 1990-09-07 | — | — | WO | disclosed |
| EP-0062611-B1 | PHOTOPOLYMERISATION PROCESS | CIBA-GEIGY AG (CH) | 1985-04-24 | — | — | EP | disclosed |
| EP-0137157-A2 | Fluid analysis technology using fluorescence type sensors | Fisher Scientific Company (US) | 1985-04-17 | — | — | EP | disclosed |
| US-4413052-A | Photopolymerization process employing compounds containing acryloyl group and anthryl group | CIBA-GEIGY CORPORATION (US) | 1983-11-01 | — | — | US | disclosed |
| EP-0062611-A2 | Photopolymerisation process | CIBA-GEIGY AG (CH) | 1982-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070215455-A1 | Isomerisation of pharmaceutical intermediates | CYP24A1, CYP2R1, VDR | CYP2D6 48/4885ALDH1A1 532/4885HSD17B10 242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.